Balancing safety and effectiveness: parent preferences for fecal microbiota transplant and established therapies in pediatric inflammatory bowel disease-results of a multicenter Canadian study.
Parents value both safety and effectiveness in IBD treatment decisions. Recognizing these preferences may support shared decision-making, particularly when discussing novel therapies like FMT.
Authors
- Karen V. MacDonald (ORCID: https://orcid.org/0000-0001-7739-4296)
- Sharlene Rozario (ORCID: https://orcid.org/0000-0003-1523-294X)
- Nikhil Pai
- Deborah A Marshall
- Anthony Otley
- Carly Burow
- Hien Q Huynh
- Jennifer C deBruyn
Institutions
- Western University (CA)
- Dalhousie University (CA)
- Children's Hospital of Philadelphia (US)
- University of Alberta (CA)
- University of Calgary (CA)
- Izaak Walton Killam Health Centre (CA)
- University of Pennsylvania (US)
- McMaster University (CA)
Publication Details
- Journal
- PubMed
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1093/crocol/otag016
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00